Literature DB >> 9322404

Working memory deficits in HIV-seropositive drug users.

J A Bartok1, E M Martin, D L Pitrak, R M Novak, K J Pursell, K M Mullane, M Harrow.   

Abstract

We studied the integrity of working memory operations in 38 HIV-seropositive and 20 seronegative drug users, using a modified version of the Tower of London task. This new task, the Tower of London-Working Memory version (TOL-WM), includes a delayed-response component in addition to the planning required for successful performance of the standard TOL. Symptomatic HIV-seropositive participants solved significantly fewer TOL-WM problems compared to matched seronegative controls. However, seropositive and seronegative subjects showed similar overall levels of planning efficiency, suggesting that the TOL-WM deficit may be associated primarily with failure to encode or maintain an adequate online memory representation. The results of this study confirm our previous report of a possible working memory deficit in HIV-1 infection and suggest that measures of working memory have particular utility in the evaluation of HIV-related cognitive deficits.

Entities:  

Mesh:

Year:  1997        PMID: 9322404

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  13 in total

1.  Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning.

Authors:  Jordan E Cattie; Katie Doyle; Erica Weber; Igor Grant; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2012-06-25       Impact factor: 2.475

2.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

3.  Verbal and spatial working memory among drug-using HIV-infected men and women.

Authors:  Eileen Martin; M K Keutmann; J S Fogel; P M Maki; R Gonzalez; J Vassileva; L H Rubin; D Hardy
Journal:  J Neurovirol       Date:  2018-04-23       Impact factor: 2.643

4.  Remote semantic memory for public figures in HIV infection, alcoholism, and their comorbidity.

Authors:  Rosemary Fama; Margaret J Rosenbloom; Stephanie A Sassoon; Megan A Thompson; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Alcohol Clin Exp Res       Date:  2010-12-01       Impact factor: 3.455

5.  Sex differences in HIV effects on visual memory among substance-dependent individuals.

Authors:  Michael K Keutmann; Raul Gonzalez; Pauline M Maki; Leah H Rubin; Jasmin Vassileva; Eileen M Martin
Journal:  J Clin Exp Neuropsychol       Date:  2016-11-13       Impact factor: 2.475

6.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

7.  Deficits in complex motor functions, despite no evidence of procedural learning deficits, among HIV+ individuals with history of substance dependence.

Authors:  Raul Gonzalez; Joanna Jacobus; Anup K Amatya; Phillip J Quartana; Jasmin Vassileva; Eileen M Martin
Journal:  Neuropsychology       Date:  2008-11       Impact factor: 3.295

Review 8.  An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research.

Authors:  Lisa R Norman; Michael Basso
Journal:  Curr Drug Abuse Rev       Date:  2015

9.  Sex and HIV serostatus differences in decision making under risk among substance-dependent individuals.

Authors:  Eileen Martin; Raul Gonzalez; Jasmin Vassileva; Pauline M Maki; Antoine Bechara; Matthias Brand
Journal:  J Clin Exp Neuropsychol       Date:  2016       Impact factor: 2.475

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.